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Mapping of the Major Psoriasis-Susceptibility Locus (PSORS1) in a 70-Kb
Interval around the Corneodesmosin Gene (CDSN)
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Numerous putative susceptibility loci have been described for psoriasis. Among the loci confirmed in the literature,
PSORS1 (the major histocompatibility complex at 6p21.3) has the strongest effect. Recent studies have highlighted
a 200-kb candidate region. However, this region has not been well delimited, mainly because of the strong linkage
equilibrium among the associated alleles. To finely map PSORS1, we set up a study using 17 polymorphic markers
in a 525-kb interval around the human leucocyte antigen C locus (HLA-C). The results uncovered five loci with
alleles strongly associated with psoriasis (Sidak-corrected P [Pc] values from 1.8 # 10
57 to .003), all structured in
a psoriasis-susceptibility haplotype (PSH). Subsequent analysis of extended haplotypes showed that the PSH was
not only present on the traditional psoriasis-susceptibility extended haplotypes (HLA-Cw6-B57, HLA-Cw6-B37,
and HLA-Cw6-B13) but also on a haplotype of Sardinian origin (HLA-Cw7-B58) found to be associated with
psoriasis ( ) because of an ancestral recombination with one of the susceptibility haplotypes carrying theP p .0009c
HLA-Cw6 allele. Comparisons of the regions identical by descent among associated and nonassociated haplotypes
highlighted a minimum region of 70 kb not recombinant with PSORS1, around the corneodesmosin (CDSN) gene.
Psoriasis (MIM 177900) is a chronic inflammatory skin
disease with a prevalence of 2% in white populations.
Skin lesions are characterized by angiogenesis, infiltrates
of activated T cells, hyperproliferation of keratinocytes,
and altered epidermal differentiation (Barker 1991).
Clear evidence for a strong genetic component in sus-
ceptibility to psoriasis arises from strong familial clus-
tering and the high concordance rate in MZ twins (Bran-
drup et al. 1982). Throughout the years, the search for
genetic susceptibility factors has been hindered by the
multifactorial nature of the disease. Early studies on dif-
ferent ethnic groups have repeatedly highlighted the
strong association of the HLA-Cw6 allele with psoriasis
(Tiilikainen et al. 1980; Roitberg-Tambur et al. 1994;
Gonzaga et al. 1996). In more recent years, genomewide
scans have made it possible to individuate new suscep-
tibility loci and to provide documented evidence of the
highly significant linkage for the 6p21.3 region, thus
confirming the presence of a major psoriasis-suscepti-
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bility gene within the major histocompatibility com-
plex (MHC) (Nair et al. 1997; Trembath et al. 1997;
Jenisch et al. 1998). These findings have led to the con-
struction of maps densely filled with genetic markers
flanking the human leucocyte antigen C locus (HLA-C
[MIM 142840]), all focused on the refinement of the
localization of PSORS1 by analysis of linkage disequi-
librium (Oka et al. 1999; Nair et al. 2000; Veal et al.
2002).
Although these studies have different conclusions,
they highlight a region of 200 kb in which alleles of the
HLA-C gene, the alpha-helix-coiled-coil-rod homolog
gene (HCR [MIM 602593]), and the corneodesmosin
gene (CDSN [MIM 602593]) have been found to be
associated with the disease. Overall, these studies con-
firm the existence, in white populations, of a strong link-
age disequilibrium region, between the HLA-C and
CDSN genes, in which it is difficult to distinguish be-
tween the susceptibility alleles and the markers in linkage
disequilibrium with these alleles. In a recent study of the
Sardinian population performed by our group, psoriasis
was found to be associated with an allele of the CDSN
gene encoding the corneodesmosin protein, without any
relationship to the HLA-C locus. Hypothetically, this
decline in linkage disequilibrium may be attributable to
Reports 165
Table 1
Single-Marker Association Study
LOCUS (LOCATIONa)
AND ALLELEb
FREQUENCY IN P VALUEc
ORCases Controls P Pc
MIB (0):
1 .273 .413 .01207 .23453 .54
C1_4_1 (18):
2 .522 .675 .00722 .14737 .53
C1_2_5 (72):
12 .286 .144 .00308 .06554 2.38
SNP 9 (15):
2 .379 .250 .01798 .32909 1.83
HLA-C (4):
5 .168 .338 .00074 .01620 .40
7 .528 .350 .00194 .04178 2.08
C1_4_3 (29):
4 .130 .325 5.70#105 .00125 .31
8 .422 .269 .00551 .11438 1.99
C1_4_4 (5):
2 .447 .281 .00295 .06292 2.07
7 .161 .356 .00011 .00252 .35
M6S172 (16):
1 .714 .481 3.41#105 .00075 2.69
4 .311 .538 6.30#105 .00139 .39
C1_2_6 (55):
2 .447 .694 1.37#105 .00030 .36
OTF-3 (8):
2 .752 .606 .00761 .15473 1.96
C1_3_2 (46):
1 .596 .363 .00005 .00099 2.60
CDSN (7):
TTC .634 .306 8.30#109 1.83#107 3.92
TGT .385 .563 .00213 .04587 .49
C2_4_4 (50):
2 .745 .538 .00017 .00363 2.52
C2_4_5 (14):
4 .646 .400 1.71#105 .00038 2.74
M6S187 (73):
6 .230 .394 .00228 .04907 .46
C4_2_7 (95):
13 .118 .206 .04617 .64649 .51
C4_4_9 (19):
5 .683 .725 .48551 1.00000 .82
a Distance (in kb) from the preceding locus.
b Allele with the largest deviation from the null hypothesis of no association.
c P is determined by the x2 two-tailed test; Pc is the P value corrected by the
Sidak test for multiple comparisons. All statistically significant values are in-
dicated in bold italics.
ancestral recombination events in this population (Orru`
et al. 2002). In an attempt to contribute to the fine map-
ping of PSORS1, we performed a case-control association
study combined with a search for identical-by-descent
(IBD) haplotypes by the use of 17 genetic markers spaced
over a region of 525 kb.
For this study, we recruited 161 unrelated Sardinian
patients with psoriasis vulgaris (90 females and 71
males; age at onset 30.4  18.8 years) and 184 indi-
viduals belonging to 32 families with multiple cases of
psoriasis. Among the families, 68 members were af-
fected. A total of 160 unrelated individuals (84 females
and 76 males; mean age 33.0  7.7 years) were used
as controls. Diagnosis of psoriasis vulgaris was based
on clinical and histological findings. Family trees were
used to document the Sardinian background in both pa-
tients and controls. After informed consent was ob-
tained, genomic DNA of each individual was isolated
from peripheral blood, in accordance with standard meth-
ods. This study was approved by the institutional review
board and by the local public-health ethics committee.
Genotyping was performed on all individuals by PCR
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Table 3
Distribution of PSH Haplotypes in Selected Patients with Psoriasis and Controls
EXCLUDED GENOTYPE
DISTRIBUTION OF
HAPLOTYPE IN P VALUEa
ORCases Controls P Pc
HLA-Cw5 87/268 31/212 51.08 # 10 .00012 2.81
C1_4_4*7 86/270 24/206 73.96 # 10 64.76 # 10 3.50
HLA-Cw6 49/222 19/260 66.47 # 10 57.77 # 10 3.59
HLA-Cw7 36/152 12/208 61.73 # 10 52.08 # 10 5.07
a P is determined by the x2 two-tailed test; Pc is the P value corrected by the Sidak
test for multiple comparisons.
using microsatellite markers MIB (Grimaldi et al. 1996);
C1_4_1, C1_2_5, C1_4_3, C_1_4_4, C1_2_6, C1_3_2,
C2_4_4, C2_4_5, C4_2_7, and C4_4_9 (Oka et al.
1999); and M6S187 and M6S172 (Nair et al. 2000).
Each PCR reaction mix was loaded onto an automated
capillary sequencer (MegaBACE 1000 [Amersham Bio-
sciences]) for electrophoretic separation and registration
of electropherograms. The alleles were defined by com-
parisons with molecular markers, by use of the Genetic
Profiler 1.1 software package (Amersham Biosciences)
and by direct inspection of the electropherograms. The
genotypes of SNP 9—located 4 kb centromeric to the
HLA-C (Veal et al. 2002)—and a polymorphism of the
OTF3 gene (MIM 164177) (Gonzalez et al. 2000) were
determined by fluorescent primer extension, with the use
of the MegaBACE SnuPe Genotyping Kit (Amersham
Biosciences). The genotypes of the HLA-B, HLA-C, and
CDSN loci were obtained as described by Orru` et al.
(2002).
The differences in frequencies between patients and
controls were evaluated by the two-tailed x2 test with 1
df. The odds ratio (OR) was calculated by 2 # 2 con-
tingency tables. Departures from Hardy-Weinberg equi-
librium and the haplotype frequencies were calculated
separately in patients and controls, by use of a Markov-
chain simulation method and the expectation-maximi-
zation (EM) algorithm, respectively, as implemented in
ARLEQUIN software (Schneider et al. 2000). To con-
struct the complete haplotypes (17 loci), a maximum of
5–6 loci at a time were analyzed. Moving from the cen-
tromeric to the telomeric portion of the haplotype, the
analysis was repeated, with the inclusion of one or two
new loci each time, until the full haplotypes were gen-
erated. To estimate haplotype frequency, a maximum of
nine loci at a time, including HLA-C and CDSN, were
assessed. Only haplotypes confirmed in families and with
a frequency 10.01 in at least one of the two groups
(patients and controls) were considered for subsequent
analysis. Less-frequent haplotypes with a variant attrib-
utable to the addition or loss of a single repeat, were
added to the corresponding more-frequent haplotype.
To estimate association between alleles of two different
loci, standardized disequilibrium values were calculated:
, where Pij corre-
′D p D / D p P  P P / P (1  P)max ij i j i j
sponds to the observed frequency of the ij haplotype and
Pi and Pj correspond to the frequencies of the i and j
alleles, respectively. Association between haplotypes and
psoriasis was also evaluated by the transmission-dis-
equilibrium test (TDT) in 32 families with multiple cases
of psoriasis, who were genotyped for all the markers
included in the present study. In this study, P values were
corrected using the Sidak test for multiple comparisons:
, where k is the number of compari-kP p 1  (1  P)c
sons. Only values !.01 were considered significant.Pc
Initially, a single-marker case-control association
study was performed on 161 cases of psoriasis and 160
controls by the use of 17 genetic markers in an MHC
class I region of ∼525 kb. Statistical comparisons were
made between the genotype frequencies of cases and
controls. Those with the strongest deviation from the
null hypothesis of no association are shown in table 1.
After correction for multiple comparisons, five loci
(M6S172, C1_3_2, CDSN, C2_4_4, and C2_4_5)
showed highly significant values for positive association
with psoriasis ( ; ). Extremely high sig-P ! .01 OR 1 2.5c
nificant values were found for the allele CDSN*TTC
( ), followed by those for the microsa-7P p 1.8 # 10c
tellites C2_4_5 ( ) and C1_3_2 ( );P p .00038 P p .0009c c
all were located in a region of 70 kb. Four loci cen-
tromeric to this region (C1_2_6, M6S172, C1_4_4, and
C1_4_5) shared alleles negatively associated with pso-
riasis ( ; ). The most centromeric andP ! .01 OR ! 0.39c
telomeric markers used in our study had no associated
alleles or only revealed a feeble association with psori-
asis. At the HLA-C locus, the allele HLA-Cw6 was not
associated with psoriasis ( ). No significant de-P p .233c
viation from the Hardy-Weinberg equilibrium was ob-
served in the two groups ( ).P 1 .05
To understand the relationship between the associated
loci, we performed a haplotype study, using the maxi-
mum-likelihood method calculated by the EM algorithm
and the reconstruction of haplotype segregation with-
in families followed by the TDT. Table 2 shows the
haplotypes obtained with psoriasis-associated loci plus
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Figure 1 Haplotypes with IBD regions. Loci and markers are listed across the top, with alleles below. The IBD regions are shown within
frames. The alleles not always present on all haplotypes are given in italics, and “–” indicates 3 variable alleles.
HLA-C and shows their distribution in the two groups—
patients and controls. The single alleles found to be as-
sociated with psoriasis were structured on three different
haplotypes, which, in turn, showed significant associa-
tion with the disease, both in the case-control association
study and in the TDT. However, whereas the negatively
associated alleles were found on a single haplotype that
exclusively carried the HLA-Cw5 alleles (haplotype D),
the positively associated alleles were present on two dif-
ferent haplotypes (haplotypes E and F) that carried the
HLA-Cw6 and HLA-Cw7 alleles, respectively, and dif-
ferent alleles at the C1_4_4 and C1_2_6 loci. The
common portion of these haplotypes (M6S172*1–
C1_3_2*1–CDSN*TTC–C2_4_4*2–C_2_4_5*4) was
present in 103 (32%) of the psoriatic chromosomes,
compared with 42 (13%) of the control chromosomes
( ; ), and was overtransmitted7P p 2.5 # 10 OR p 3.1c
within families (transmitted p 26; not transmitted p
5; ). This haplotype, which we defined as theP p .0002
“psoriasis-susceptibility haplotype” (PSH), was almost
exclusively carried by the E and F haplotypes—since its
presence in other haplotypes was rare (four in patients
and three in controls)—and, even so, was not correlated
to a specific haplotype. As is summarized in table 3, the
increased frequency of PSH observed in patients did not
depend on a decreased frequency of the D haplotype
(HLA-Cw5 and C1_4_4*7 genotypes excluded) or an
increased frequency of the E (HLA-Cw6) and F (HLA-
Cw7) haplotypes.
Finally, the construction of the haplotypes, by use of
all loci analyzed in the present study (fig. 1), made it
possible to search for alleles shared by different haplo-
types and to further clarify the nature of the association
of PSH with psoriasis. As concerns the two haplotypes
with PSH, the E haplotype was found to be the sum of
three extended haplotypes (EHs), Cw6-B13 (EH13.1),
Cw6-B37 (EH37.1), and Cw6-B57 (EH57.1), whereas
the F haplotype corresponded to the extended haplotype
HLA-Cw7-B58 (EH58.1).
Thorough examination of the haplotypes from locus
C1_2_5 to locus C2_4_5 revealed three IBD regions.
These regions are represented within frames in figure 1.
The largest frame corresponds to the cluster of Cw6
haplotypes and includes the alleles from C1_2_5 to
C2_4_5 (250 kb). The two allelic variants in the C1_2_5
and C1_2_6 loci may be the result of slippage-mispairing
mutations. This block of alleles has been reported else-
where (Nair et al. 2000), and the markers in common
that are used in the present study confirm its structure.
The smallest frame coincided with OTF3*2 and in-
cluded four of the five PSH alleles. However, it is possible
that the recombination event did not involve the cen-
tromeric end of PSH but that it occurred between the
C1_2_6 and OTF3 loci as the result of a noncontiguous
allele at the C1_2_6 locus. The HLA-Cw8-B65 (EH65.1)
haplotype was included in the table, because it contained
a region of 85 kb IBD to the cluster of Cw6 haplotypes.
On the basis of the association data found for this hap-
lotype (haplotype H; see table 2), it seemed possible to
rule out this region. Hence, the minimum region non-
recombinant with PSH can be restricted to the loci
C1_3_2–C2_4_5. We conclude that this region has the
highest probability of containing PSORS1.
Of the 13 microsatellite markers investigated in the
present study, 10 corresponded to those studied by Nair
et al. (2000). This enabled us to search for PSH alleles
(CDSN excluded) among the 66 clusters of haplotypes
identified by those authors in Northern European white
families. The results of our search showed that PSH—
or the portion C1_3_2–C2_4_5, in which we mapped
PSORS1—was exclusively present on haplotypes 19–25,
corresponding to the cluster of haplotypes HLA-Cw6.
The first important finding emerging from this data is
that the genetic background of the Sardinian population,
with respect to PSORS1, is the same as that of other
white populations and that the recently reported lack of
association between the HLA-C alleles and psoriasis
(Orru` et al. 2002) is not the result of the genetic het-
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Table 4
Distribution of Genotypes in Selected Individuals
SUBJECT GROUP AND CHARACTERISTIC CDSN*TTC SNP 9*2 HLA-Cw6 HLA-Cw7
CDSN*TTC negative:
No. of cases with genotype ( )n p 59 - 14 3 23
No. of controls with genotype ( )n p 111 - 21 11 28
Pc - .99998 .99872 .68380
OR - 1.33 .49 1.89
SNP 9*2 negative:
No. of cases with genotype ( )n p 100 55 - 7 68
No. of controls with genotype ( )n p 120 30 - 7 46
Pc .00012 - 1 .00026
OR 3.67 - .93 3.42
HLA-Cw6 negative:
No. of cases with genotype ( )n p 111 55 18 - 71
No. of controls with genotype ( )n p 130 30 19 - 48
Pc .00039 1 - .00059
OR 3.27 1.3 - 3.03
HLA-Cw7 negative:
No. of cases with genotype ( )n p 76 40 44 36 -
No. of controls with genotype ( )n p 104 21 30 22 -
Pc .00014 .00205 .00451 -
OR 4.39 3.39 3.35 -
erogeneity of the population but is, instead, a likely con-
sequence of an ancestral recombination between one of
the Cw6 haplotypes and the HLA-Cw7-B58 haplotype.
Another important outcome of our study is the definitive
exclusion of the loci centromeric to the M6S172 marker—
including the HLA-C locus—from the PSORS1 candidate
region.
The HCR and CDSN genes map inside the PSORS1
critical region defined in the present study. Both genes
have been investigated recently in numerous association
studies, because, at a functional level, they are good
candidates for psoriasis susceptibility (Simon et al. 1997;
Asumalahti et al. 2002; Elomaa et al. 2004). In addition,
SPR1, SEEK1, and STG map to this region, and, al-
though functional data is lacking for these genes, their
specific expression in the skin (Holm et al. 2003) has
aroused considerable interest. Some polymorphisms of
the CDSN gene have been found to be associated with
psoriasis, but these associations have been attributed to
linkage disequilibrium with HLA-Cw6 (Jenisch et al.
1999; Guerrin et al. 2001; Asumalahti et al. 2002). This
can be explained by the block of IBD alleles carried by
haplotypes of the Cw6 cluster in an ∼250-kb region from
the C1_2_5 marker (19 kb centromeric to HLA-C) to
the C2_4_5 marker (60 kb telomeric to CDSN), as doc-
umented in this and other reports (Nair et al. 2000). In
the Sardinian population, an ancestral recombination
has confined this block of linkage disequilibrium to the
PSH region.
Other studies do not confirm the association of the
CDSN gene with psoriasis (Gonzalez et al. 2000; Chang
et al. 2003), probably because the association of CDSN
and HCR is mostly linked to intragenic haplotypes of
SNPs (Jenisch et al. 1999; Asumalahti et al. 2002) and
is not always uncovered when the SNPs are considered
separately. Our findings support the hypothesis that the
CDSN*TTC allele is involved in the disease. Major op-
position to this hypothesis arises from the fact that this
allele was not found to be associated with psoriasis in
Thai (Romphruk et al. 2003) and Japanese (Hui et al.
2002) populations. On the basis of the recent identifi-
cation of a psoriasis-risk haplotype that conserves the
SNP9*2 and CDSN*TTC alleles, an equal role for
HLA-C and CDSN in psoriasis susceptibility has been
suggested (Capon et al. 2003). Since the CDSN*TTC
allele had the strongest association in our study, we de-
cided to investigate the effect of HLA-C alleles on this
association. The results summarized in table 4 show that
the influence exerted by these alleles was irrelevant. The
strength of association found for the CDSN*TTC allele
was only slightly decreased in patients and controls neg-
atively selected for the alleles HLA-Cw6 and SNP9*2
( and 3.7, respectively), compared with theOR p 3.3
total sampling ( ), and was even increased inOR p 3.9
samples negatively selected for HLA-Cw7 ( ).OR p 4.4
In contrast, HLA-C alleles are completely dependent on
CDSN*TTC, since they lose any tendency whatsoever
toward association with psoriasis when this allele is ex-
cluded from the sampling.
Although our data demonstrate the independence of
the association with the CDSN*TTC allele, they do not
make it possible to differentiate the effect that this allele
has on the rest of the region in which we map PSORS1.
However, it is likely that minor loci interact with PSORS1
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in the predisposition to psoriasis. The existence of IBD
regions in different HLA psoriasis-susceptibility haplo-
types implies that such haplotypes have the same sus-
ceptibility allele and therefore confer an identical risk of
psoriasis. The data obtained in this study seem to in-
dicate that haplotypes of the HLA-Cw6 cluster confer
a higher risk of psoriasis than the HLA-Cw7-B58 hap-
lotype ( vs. 3.6). The three haplotypes of theOR p 5.1
Cw6 cluster were elsewhere shown to confer different
levels of risk for psoriasis (Jenisch et al. 1998), sug-
gesting that other genetic factors mapping in the MHC
region may interact with PSORS1. A precious tool to
enlighten this aspect will be comparisons among recom-
binant portions of psoriasis-risk haplotypes. The discov-
ery of the recombinant HLA-Cw7-B58 haplotype should
contribute toward unraveling the etiology of psoriasis.
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